Ranibizumab versus verteporfin for neovascular age-related macular degeneration.
N Engl J Med. 2006 Oct 5;355(14):1432-44. doi: 10.1056/NEJMoa062655.
N Engl J Med. 2006.
PMID: 17021319
Free article.
Clinical Trial.